US Health and Human Services Secretary Robert F. Kennedy Jr. attacks scientific literature with censorship to push MAHA ...

Patients with previously treated metastatic pancreatic cancer who took an oral once-daily pill called daraxonrasib lived ...

The prevalence of overweight and obesity represents a global public health challenge 1. Incretin mimetic therapies, including glucagon-like peptide 1 (GLP-1) receptor agonists and dual ...

A transgender teen tested Roo, Planned Parenthood's AI-powered sexual health chatbot, which includes LGBTQ+ health topics, ...

Patients with metastatic pancreatic cancer who received the experimental drug elraglusib alongside standard chemotherapy saw ...

FDA’s draft “plausible mechanism” framework gives individualized genetic therapies a clearer path to market, but questions remain, write experts at Morrison Foerster.

The incidence of obesity is increasing globally, leading to elevated risk for mortality and comorbidities and increased healthcare costs. GLP-1 RAs that mimic the effects of GLP-1, an incretin hormone ...

Scaling effective solutions often stalls in state government because funding systems are not designed to reward proof of ...

Galectin Therapeutics is a Buy as recent FDA alignment de-risks belapectin’s Phase 3 path and clarifies regulatory endpoints.

There has been growing recognition that gut health may play a role in Parkinson’s disease—a brain disorder. This article ...

Previous research has associated the live-attenuated shingles vaccine to a lower risk of developing dementia. Now, an ...

Nothing about long Covid adds up. All of this is very strange. Stranger still are patients’ stories of astonishing recoveries ...